The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
Abstract
Purpose: To determine the association between tumor hypoxia, treatment regimen, and locoregional failure (LRF) in patients with stage III or IV squamous cell carcinoma of the head and neck randomly assigned to radiotherapy (70 Gy in 35 fractions over 7 weeks) plus either tirapazamine and cisplatin in weeks 1, 4, and 7 and tirapazamine alone in weeks 2 and 3 (TPZ/CIS) or cisplatin and infusional fluorouracil during weeks 6 and 7 (chemoboost). Patients and Methods: Forty-five patients were enrolled onto a hypoxic imaging substudy of a larger randomized trial. Pretreatment and midtreatment [18 F]-fluoromisonidazole positron emission tomography scans (FMISO-PET) were performed 2 hours after tracer administration, with qualitative scoring of uptake in both primary tumors and nodes. Results: Thirty-two patients (71%) had detectable hypoxia in either or both primary and nodal disease. In patients who received chemoboost, one of 10 patients without hypoxia had LRF compared with eight of 13 patients with hypoxia; the risk of LRF was significantly higher in hypoxic patients (exact log-rank, P = .038; hazard ratio [HR] = 7.1). By contrast, in patients who received the TPZ/CIS regimen, only one of 19 patients with hypoxic tumors had LRF; risk of LRF was significantly higher in chemoboost patients (P = .001; HR = 15). Similarly, looking at the primary site alone, in patients with hypoxic primaries, zero of eight patients treated with TPZ/CIS experienced failure locally compared with six of nine patients treated with chemoboost (P = .011; HR = 0). Conclusion: Hypoxia on FMISO-PET imaging, in patients receiving a nontirapazamine-containing chemoradiotherapy regimen, is associated with a high risk of LRF. Our data provide the first clinical evidence to support the experimental observation that tirapazamine acts by specifically targeting hypoxic tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Adelstein, D. J., Li, Y., Adams, G. L., Wagner, H., Kish, J. A., Ensley, J. F., Schuller, D. E., & Forastiere, A. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.008 · Cited by 1,748
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., & Dewhirst, M. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00101-6 · Cited by 1,068
Calais, G., Alfonsi, M., Bardet, E., Sire, C., Germain, T., Bergerot, P., Rhein, B., Tortochaux, J., Oudinot, P., & Bertrand, P. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2081 · Cited by 1,060
Nordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942
Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., & Broder, G. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90002-8 · Cited by 798
(2001) · PubMed · Cited by 605
SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K., & Lee, W. W. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90267-1 · Cited by 402
Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H., Talks, K., Gatter, K. C., & Harris, A. L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02848-1 · Cited by 361
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders, J. H. A. M., Wijffels, K. I. E. M., Marres, H. A. M., Ljungkvist, A. S. E., Pop, L. A. M., van den Hoogen, F. J. A., de Wilde, P. C. M., Bussink, J., Raleigh, J. A., & van der Kogel, A. J. (2002) · PubMed · Cited by 357
von Pawel, J., von Roemeling, R., Gatzemeier, U., Boyer, M., Elisson, L. O., Clark, P., Talbot, D., Rey, A., Butler, T. W., Hirsh, V., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1351 · Cited by 285
Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274
Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
Stadler, P., Becker, A., Jürgen Feldmann, H., Hänsgen, G., Dunst, J., Würschmidt, F., & Molls, M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00115-7 · Cited by 266
Prognostic significance of tumor oxygenation in humans
Evans, S. M., & Koch, C. J. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00012-0 · Cited by 259
Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253
Self-citationLe, Q., Sutphin, P. D., Raychaudhuri, S., Yu, S. C. T., Terris, D. J., Lin, H. S., Lum, B. L., Pinto, H. A., Koong, A. C., & Giaccia, A. J. (2003) · PubMed · Cited by 216
Rischin, D., Peters, L., Hicks, R., Hughes, P., Fisher, R., Hart, R., Sexton, M., D’Costa, I., & von Roemeling, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.535 · Cited by 201
Self-citationKoukourakis, M. I., Giatromanolaki, A. N., Sivridis, E., Simopoulos, K., Pastorek, J., Wykoff, C. C., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 200
Garden, A. S., Harris, J., Vokes, E. E., Forastiere, A. A., Ridge, J. A., Jones, C., Horwitz, E. M., Glisson, B. S., Nabell, L., Cooper, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.012 · Cited by 186
Brown, J. M., & Lemmon, M. J. (1990) · PubMed · Cited by 181
Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.
Dorie, M. J., & Brown, J. M. (1993) · PubMed · Cited by 143
Hicks, R. J., Rischin, D., Fisher, R., Binns, D., Scott, A. M., & Peters, L. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1880-2 · Cited by 141
Self-citationJanssen, H. L., Haustermans, K. M., Sprong, D., Blommestijn, G. J. F., Hofland, I., Hoebers, F. J. P., Blijweert, E., Raleigh, J. A., Semenza, G. L., Varia, M. A., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03935-4 · Cited by 132
Becker, A., Hänsgen, G., Bloching, M. B., Weigel, C., Lautenschläger, C., & Dunst, J. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00182-5 · Cited by 127
Rudat, V., Stadler, P. F., Becker, A., Vanselow, B., Dietz, A., Wannenmacher, M., Molls, M., Dunst, J., & Feldmann, H. J. (2001) · Strahlentherapie und Onkologie · doi:10.1007/pl00002427 · Cited by 95
Corry, J. F., Rischin, D., Smith, J., D’Costa, I., Huges, P. G., Sexton, M., Sizeland, A. M., Lyons, B. M., & Peters, L. J. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00182-6 · Cited by 59
Self-citationGarden, A. S., Glisson, B. S., Ang, K. K., Morrison, W. H., Lippman, S. M., Byers, R. M., Geara, F. B., Clayman, G. L., Shin, D. M., Callender, D. L., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2390 · Cited by 52
Self-citationPhase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
Senan, S., Rampling, R. P., Graham, M. A., Wilson, P., Robin, H., Eckardt, N., Lawson, N. M., McDonald, A. C., von Roemeling, R., Workman, P., et al. (1997) · PubMed · Cited by 48
Le, Q., Kovacs, M. S., Dorie, M. J., Koong, A. C., Terris, D. J., Pinto, H. A., Goffinet, D. R., Nowels, K. W., Bloch, D. A., & Brown, J. M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04503-0 · Cited by 43
Dorie, M. J., Menke, D., & Brown, J. M. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90152-x · Cited by 40
Tumor hypoxia is important in radiotherapy, but how should we measure it?
Brown, J. M., & Le, Q. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03936-6 · Cited by 36
Vanselow, B., Eble, M. J., Rudat, V., Wollensack, P., Conradt, C., & Dietz, A. (2000) · Otolaryngology · doi:10.1016/s0194-59980070014-3 · Cited by 31
Corry, J. F., & Rischin, D. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.005 · Cited by 29
Self-citation
Cited by
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Liu, J.-N., Bu, W., & Shi, J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00525 · Cited by 838
Rischin, D., Young, R. J., Fisher, R., Fox, S. B., Le, Q.-T., Peters, L. J., Solomon, B., Choi, J., O'Sullivan, B., Kenny, L. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2904 · Cited by 737
Self-citation
Metadata
- Authors
- Rischin, D., Hicks, R. J., Fisher, R., Binns, D., Corry, J., Porceddu, S., & Peters, L. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-05-01
- Volume
- 24
- Issue
- 13
- Pages
- 2098-2104
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2136800292
- Cited by
- 541
- References
- 34
- FWCI
- 40.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.